Skip to content

Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Me-chanical Ventilation - Effects on Cognitive Function

Substudy of the NONSEDA Trial (NCT01967680): Non-sedation Versus Sedation With a Daily Wake-up Trial in Critically Ill Patients Receiving Me-chanical Ventilation - Effects on Cognitive Function

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02035436
Enrollment
205
Registered
2014-01-14
Start date
2014-01-31
Completion date
2019-03-31
Last updated
2019-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognition Disorders, Delirium

Keywords

Respiration, artificial, Critcal care

Brief summary

Through many years, the standard care has been to use continuous sedation of critically ill patients during mechanical ventilation. However, preliminary randomised clinical trials indicate that it is beneficial to reduce the sedation level in these patients. The NONSEDA trial is an investigator-initiated, randomised, clinical, parallel-group, multinational, superiority trial designed to include 700 patients from at least six ICUs in Denmark, Norway and Sweden, comparing no sedation with sedation and a daily wake-up trial during mechanical ventilation. This is a substudy of the NONSEDA trial, concerning 250 patients included at trialsite Kolding, Denmark. The aim of the substudy is to assess the effects of no sedation on delirium during admission and cognitive function after discharge from ICU. Our hypothesis is that critically ill patients who are not sedated during mechanical ventilation will have better cognitive function after discharge.

Interventions

Patients are awake or have natural sleep during mechanical ventilation. Pain is treated with morphine iv.

OTHERControl: Sedation

Continuous iv-sedation (propofol first 48 hours, from then midazolam) to Ramsey 3-4 with a daily wake up attempt, where sedation is stopped until patient is awake.

Sponsors

Palle Toft
Lead SponsorOTHER
Kolding Sygehus
CollaboratorOTHER
University of Southern Denmark
CollaboratorOTHER
The Danish Council for Strategic Research
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Endotracheally intubated * Expected time on ventilator \> 24 hours * Age ≥ 18 years * Informed consent

Exclusion criteria

* Severe head trauma where therapeutic coma is indicated * Therapeutic hypothermia where therapeutic coma is indicated * Status epilepticus where therapeutic coma is indicated * Patient has participated in the study before * Patient is transferred from another ICU with length of stay \> 48 hours * Patient is comatose at admission * PaO2/FiO2 ≤ 9, if sedation is necessary for oxygenation * Patient does not speak Danish, swedish or norwegian at a reasonable level

Design outcomes

Primary

MeasureTime frameDescription
Cognitive function3 months after discharge from ICUCognitive t-score, in percentage, difference between the two groups. The t-score for each patient will be diagnosed by the neuropsycologist at a personal interview and use of following tests: * Span of numbers * Coding test * Trailmaking A+B * Rey auditory verbal learning test (immediate, recall) * Rey-Ostherrieth complex figure test (immediate, recall, recognition) * Word finding test (S-word, animals) * Stroop test (congruent+incongruent)

Secondary

MeasureTime frameDescription
Learning/memory3 months after discharge from ICUt-score in the two groups for the cognitive domaine: learning/memory
Executive dysfunction3 months after discharge from ICUt-score in the two groups for the cognitive domaine: executive dysfunction
Attention/concentration3 months after discharge from ICUT-score in the two groups for the cognitive domaine attention/concentration
Hypoactive delirium3 months after discharge from ICUOccurrence of hypoactive delirium (RASS ≤ 0, CAM-ICU positive) in each group related to cognitive function at follow up
Agitated delirium3 months after discharge from ICUOccurrence of agitated delirium (RASS ≥ +2, CAM-ICU positive) in each group related to cognitive function at follow up
Mental pace3 months after discharge from ICUt-score in the two groups for the cognitive domaine: mental pace

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026